Prosecution Insights
Last updated: April 19, 2026

Pahr Therapeutics Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
0
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18034461 COMBINATION OF AN AHR INHIBITOR WITH A PDX INHIBITOR OR DOXORUBICINE ROBINSON, MIKHAIL O'DONNEL 1627 Non-Final OA Apr 28, 2023
17791608 AHR INHIBITORS AND USES THEREOF LADD, CAROLYN LOUISE 1622 Non-Final OA Jul 08, 2022
17779893 AHR INHIBITORS AND USES THEREOF HEITMEIER, KENDALL NICOLE 1621 Non-Final OA May 25, 2022

Managing Pahr Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month